Arestin beta 1
Arestin, beta 1 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
![]() PDB prikaz baziran na 1g4m. | |||||||||||
Dostupne strukture | |||||||||||
1g4m, 1g4r, 1jsy, 1zsh | |||||||||||
Identifikatori | |||||||||||
Simboli | ARRB1; ARB1; ARR1 | ||||||||||
Vanjski ID | OMIM: 107940 MGI: 99473 HomoloGene: 2981 GeneCards: ARRB1 Gene | ||||||||||
| |||||||||||
Pregled RNK izražavanja | |||||||||||
![]() | |||||||||||
podaci | |||||||||||
Ortolozi | |||||||||||
Vrsta | Čovek | Miš | |||||||||
Entrez | 408 | 109689 | |||||||||
Ensembl | ENSG00000137486 | ENSMUSG00000018909 | |||||||||
UniProt | P49407 | Q8BWG8 | |||||||||
RefSeq (mRNA) | NM_004041 | NM_177231 | |||||||||
RefSeq (protein) | NP_004032 | NP_796205 | |||||||||
Lokacija (UCSC) | Chr 11: 74.65 - 74.74 Mb | Chr 7: 99.41 - 99.48 Mb | |||||||||
PubMed pretraga | [1] | [2] |
Arestin beta 1, ARRB1, je protein koji je čoveka kodiran ARRB1 genom.[1][2]
Funkcije
Za članove arestin/beta-arestin proteinske familije se smatra da učestvuju u agonistima posredovanoj desenzitizaciji G protein-spregnutih receptora i uzrokuju specifično prigušivanje ćelijskog responsa na stimuluse kao što su hormoni, neurotransmitera, ili senzorski signali. Arrestin beta 1 je citosolni protein koji deluje kao kofaktor u beta-adrenergičkom receptorskom kinazom (BARK) posredovanoj desenzitizaciji beta-adrenergičkog receptora. Pored centralnog nervnog sistema, on je izražen u visokim nivoima u perifernim krvnim leukocitima, i stoga se za BARK/beta-arestinski sistem da ima značajnu ulogu u regulaciji receptorom-posredovanih imunskih funkcija. Alternativno splajsovani transkripti kodiraju različite izoforme arestina beta 1. One su bile opisane, međutim, njihove precizne funkcije nisu poznate.[2]
Interakcije
Za arestin beta 1 je bilo pokazano da interaguje sa delta opioidnim receptorom,[3] Arf6,[4] paratiroidnom hormonu srodnim proteinom,[5] RALGDS,[6] PSCD2,[4] DVL2[7] i Mdm2.[8][9]
Reference
- ^ Parruti G, Peracchia F, Sallese M, Ambrosini G, Masini M, Rotilio D, De Blasi A (1993). „Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing”. The Journal of Biological Chemistry. 268 (13): 9753—61. PMID 8486659. Архивирано из оригинала 03. 01. 2005. г. Приступљено 04. 04. 2011.
- ^ а б „Entrez Gene: ARRB1 arrestin, beta 1”.
- ^ Cen, B; Yu Q (2001). „Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor”. J. Neurochem. United States. 76 (6): 1887—94. ISSN 0022-3042. PMID 11259507. doi:10.1046/j.1471-4159.2001.00204.x.
- ^ а б Claing, A; Chen W (2001). „beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis”. J. Biol. Chem. United States. 276 (45): 42509—13. ISSN 0021-9258. PMID 11533043. doi:10.1074/jbc.M108399200.
- ^ Conlan, Lindus A; Martin T John; Gillespie Matthew T (2002). „The COOH-terminus of parathyroid hormone-related protein (PTHrP) interacts with beta-arrestin 1B”. FEBS Lett. Netherlands. 527 (1-3): 71—5. ISSN 0014-5793. PMID 12220636. doi:10.1016/S0014-5793(02)03164-2.
- ^ Bhattacharya, Moshmi; Anborgh Pieter H; Babwah Andy V; Dale Lianne B; Dobransky Tomas; Benovic Jeffery L; Feldman Ross D; Verdi Joseph M; Rylett R Jane; Ferguson Stephen S G (2002). „Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization”. Nat. Cell Biol. England. 4 (8): 547—55. ISSN 1465-7392. PMID 12105416. doi:10.1038/ncb821.
- ^ Chen, W; Hu L A; Semenov M V; Yanagawa S; Kikuchi A; Lefkowitz R J; Miller W E (2001). „beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins”. Proc. Natl. Acad. Sci. U.S.A. United States. 98 (26): 14889—94. ISSN 0027-8424. PMC 64954
. PMID 11742073. doi:10.1073/pnas.211572798.
- ^ Wang, Ping; Wu Yalan; Ge Xin; Ma Lan; Pei Gang (2003). „Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus”. J. Biol. Chem. United States. 278 (13): 11648—53. ISSN 0021-9258. PMID 12538596. doi:10.1074/jbc.M208109200.
- ^ Shenoy, Sudha K; Xiao Kunhong; Venkataramanan Vidya; Snyder Peter M; Freedman Neil J; Weissman Allan M (2008). „Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor”. J. Biol. Chem. United States. 283 (32): 22166—76. ISSN 0021-9258. PMC 2494938
. PMID 18544533. doi:10.1074/jbc.M709668200.
Literatura
- Lefkowitz RJ (1998). „G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization.”. J. Biol. Chem. 273 (30): 18677—80. PMID 9668034. doi:10.1074/jbc.273.30.18677.
- Lohse MJ; Benovic JL; Codina J (1990). „beta-Arrestin: a protein that regulates beta-adrenergic receptor function.”. Science. 248 (4962): 1547—50. PMID 2163110. doi:10.1126/science.2163110.
- Calabrese G; Sallese M; Stornaiuolo A (1995). „Assignment of the beta-arrestin 1 gene (ARRB1) to human chromosome 11q13.”. Genomics. 24 (1): 169—71. PMID 7896272. doi:10.1006/geno.1994.1594.
- Parruti G; Peracchia F; Sallese M (1993). „Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing.”. J. Biol. Chem. 268 (13): 9753—61. PMID 8486659.
- Iacovelli L, Franchetti R, Masini M, De Blasi A (1997). „GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.”. Mol. Endocrinol. 10 (9): 1138—46. PMID 8885248. doi:10.1210/me.10.9.1138.
- Bonaldo MF, Lennon G, Soares MB (1997). „Normalization and subtraction: two approaches to facilitate gene discovery.”. Genome Res. 6 (9): 791—806. PMID 8889548. doi:10.1101/gr.6.9.791.
- Goodman OB; Krupnick JG; Gurevich VV (1997). „Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain.”. J. Biol. Chem. 272 (23): 15017—22. PMID 9169477. doi:10.1074/jbc.272.23.15017.
- Lin FT; Krueger KM; Kendall HE (1998). „Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1.”. J. Biol. Chem. 272 (49): 31051—7. PMID 9388255. doi:10.1074/jbc.272.49.31051.
- Aragay AM; Mellado M; Frade JM (1998). „Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2.”. Proc. Natl. Acad. Sci. U.S.A. 95 (6): 2985—90. PMC 19681
. PMID 9501202. doi:10.1073/pnas.95.6.2985.
- ter Haar E, Musacchio A, Harrison SC, Kirchhausen T (1998). „Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker.”. Cell. 95 (4): 563—73. PMID 9827808. doi:10.1016/S0092-8674(00)81623-2.
- Luttrell LM; Ferguson SS; Daaka Y (1999). „Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.”. Science. 283 (5402): 655—61. PMID 9924018. doi:10.1126/science.283.5402.655.
- McDonald PH; Cote NL; Lin FT (1999). „Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation.”. J. Biol. Chem. 274 (16): 10677—80. PMID 10196135. doi:10.1074/jbc.274.16.10677.
- Lin FT, Miller WE, Luttrell LM, Lefkowitz RJ (1999). „Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases.”. J. Biol. Chem. 274 (23): 15971—4. PMID 10347142. doi:10.1074/jbc.274.23.15971.
- McConalogue K; Déry O; Lovett M (1999). „Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.”. J. Biol. Chem. 274 (23): 16257—68. PMID 10347182. doi:10.1074/jbc.274.23.16257.
- Miller WE; Maudsley S; Ahn S (2000). „beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.”. J. Biol. Chem. 275 (15): 11312—9. PMID 10753943. doi:10.1074/jbc.275.15.11312.
- Laporte SA; Oakley RH; Holt JA (2000). „The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits.”. J. Biol. Chem. 275 (30): 23120—6. PMID 10770944. doi:10.1074/jbc.M002581200.
- Bennett TA, Maestas DC, Prossnitz ER (2000). „Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.”. J. Biol. Chem. 275 (32): 24590—4. PMID 10823817. doi:10.1074/jbc.C000314200.
- Shiina T, Kawasaki A, Nagao T, Kurose H (2000). „Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors.”. J. Biol. Chem. 275 (37): 29082—90. PMID 10862778. doi:10.1074/jbc.M909757199.
- Barlic J; Andrews JD; Kelvin AA (2001). „Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.”. Nat. Immunol. 1 (3): 227—33. PMID 10973280. doi:10.1038/79767.
- п
- р
- у
- 1g4m: Kristalna struktura goveđeg beta-arestina 1
- 1g4r: Kristalna struktura goveđeg beta-arestina 1
- 1jsy: Kristalna struktura goveđeg beta-arestina 2
- 1zsh: Kristalna struktura goveđeg beta-arestina 2 u kompleksu sa inozitol heksakisfosfatom (IP6)